Request a copy of the file

Enter the following information to request a copy for the following item: Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Requesting the following file: 2019_Saura_Lancet_Oncol.pdf